The story
Founded by Wilson Greatbatch in 1970.1
ITGR on NYSE
American medical technology company.1
$126.72 up 0.12 (0.09%)Price as of Oct 15, 2026 at 17:33 UTC
Last updated Oct 19, 2026.
Compare with LivaNova PLC, CONMED Corporation or TransMedics Group, Inc., or pick any stock.
See how the biggest companies compare on our leaderboards
Integer Holdings Corporation, headquartered in Plano, Texas, is one of the world’s largest medical device contract development and manufacturing organizations (“CDMOs”), serving the Cardio and Vascular, Neuromodulation, and Cardiac Rhythm Management markets. As a strategic partner of choice, we advance the goals of our medical device customers through industry-leading engineering and manufacturing, with a relentless commitment to quality, service, and innovation. Our brands include Greatbatch Medical ® and Lake Region Medical ® . Our primary customers include large, multi-national original equipment manufacturers (“OEMs”) and their affiliated subsidiaries. When used in this report, the terms “Integer,” “we,” “us,” “our” and the “Company” mean Integer Holdings Corporation and its subsidiaries.5 From its latest annual report
From the company’s reports to the SEC. Every number links to the filing it came from.
Revenue by product, business segment and region, as the company reports it to the SEC.
Cardio And Vascular brought in 60% of the revenue Integer broke down this way in fiscal 2025.
| Products and services | 2023 | 2024 | 2025 |
|---|---|---|---|
| Cardio And Vascular | $836.3M | $949.6M | $1.1B |
| Cardiac Rhythm Management & Neuromodulation | $612.9M | $660.6M | $668.8M |
| Other Markets | $106.4M | $106.4M | $77.8M |
United States brought in 53% of the revenue Integer broke down this way in fiscal 2025.
| Regions | 2023 | 2024 | 2025 |
|---|---|---|---|
| United States | $872.9M | $938.7M | $979.8M |
| Rest Of World | $383.7M | $431.8M | $469.9M |
| CR | $108.4M | $124.7M | $173.5M |
| PR | $121.5M | $137.1M | $131.3M |
| I E | $69.1M | $84.4M | $99.2M |
Out of $1.9B in revenue.6
Out of $196.1M of cash from operations.6
Every line of the income statement as filed: the last 3 fiscal years, latest first.6
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Sales | $1.9B | $1.7B | $1.6B |
| Cost of sales | $1.4B | $1.3B | $1.1B |
| Gross profit | $500.4M | $459.0M | $409.9M |
| Selling, general and administrative | $211.7M | $185.2M | $173.2M |
| Research, development and engineering | $49.5M | $53.4M | $62.0M |
| Restructuring and other charges | $17.9M | $12.1M | $11.4M |
| Total operating expenses | $279.1M | $250.8M | $246.6M |
| Operating income | $221.3M | $208.2M | $163.3M |
| Interest expense | $43.2M | $56.4M | $51.3M |
| (Gain) loss on equity investments, net | -$550.0K | $780.0K | $5.7M |
| Other loss, net | $53.2M | $3.5M | $975.0K |
| Income from continuing operations before income taxes | $125.4M | $147.6M | $105.4M |
| Provision for income taxes | $22.6M | $26.5M | $16.2M |
| Income from continuing operations | $102.8M | $121.1M | $89.1M |
| Income (loss) from discontinued operations, net of tax | -$22.0K | -$1.2M | $1.5M |
| Net income | $102.8M | $119.9M | $90.7M |
| Income from continuing operations (in dollars per share) | $3 | $4 | $3 |
| Income from discontinued operations (in dollars per share) | $0 | -$0 | $0 |
| Basic earnings per share (in dollars per share) | $2.96 | $3.57 | $2.72 |
| Income from continuing operations (in dollars per share) | $3 | $3 | $3 |
| Income (loss) from discontinued operations (in dollars per share) | $0 | -$0 | $0 |
| Diluted earnings per share (in dollars per share) | $2.89 | $3.36 | $2.69 |
| Basic (in shares) | 34.7M shares | 33.6M shares | 33.3M shares |
| Diluted (in shares) | 35.6M shares | 35.6M shares | 33.8M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.6
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $17.2M | $46.5M | ||
| Accounts receivable, net of provision for credit losses of $0.6 million and $0.3 million, respectively | $346.1M | $245.3M | ||
| Inventories | $253.7M | $247.1M | ||
| Contract assets | $112.5M | $103.8M | ||
| Prepaid expenses and other current assets | $40.6M | $28.4M | ||
| Total current assets | $770.1M | $671.1M | ||
| Property, plant and equipment, net | $536.4M | $465.8M | ||
| Goodwill | $1.1B | $1.0B | $994.0M | |
| Other intangible assets, net | $825.4M | $778.3M | ||
| Deferred income taxes | $9.0M | $8.3M | ||
| Operating lease assets | $98.4M | $86.1M | ||
| Financing lease assets | $37.1M | $27.7M | ||
| Other long-term assets | $23.2M | $23.0M | ||
| Total assets | $3.4B | $3.1B | ||
| Current portion of long-term debt | $0 | $10.0M | ||
| Accounts payable | $113.1M | $101.5M | ||
| Operating lease liabilities | $9.1M | $7.4M | ||
| Accrued expenses and other current liabilities | $109.8M | $108.3M | ||
| Total current liabilities | $232.0M | $227.2M | ||
| Long-term debt | $1.2B | $980.2M | ||
| Deferred income taxes | $116.3M | $124.6M | ||
| Operating lease liabilities | $81.9M | $77.7M | ||
| Financing lease liabilities | $28.6M | $23.8M | ||
| Other long-term liabilities | $19.9M | $25.4M | ||
| Total liabilities | $1.7B | $1.5B | ||
| Preferred stock, $0.001 par value, authorized 100,000,000 shares; no shares issued or outstanding | $0 | $0 | ||
| Common stock, $0.001 par value; 100,000,000 shares authorized; 35,481,805 and 33,546,262 shares issued, respectively, and 34,346,450 and 33,546,256 outstanding, respectively | $35.0K | $34.0K | ||
| Additional paid-in capital | $771.2M | $742.0M | ||
| Treasury stock, at cost, 1,135,355 shares and 6 shares, respectively | -$76.9M | $0 | ||
| Retained earnings | $994.1M | $891.2M | ||
| Accumulated other comprehensive income (loss) | $58.2M | -$14.0M | ||
| Total stockholders equity | $1.7B | $1.6B | $1.5B | $1.4B |
| Total liabilities and stockholders equity | $3.4B | $3.1B | ||
| Allowance for doubtful accounts | $600.0K | $300.0K | ||
| Preferred stock, par value (in dollars per share) | $0.00 | $0.00 | ||
| Preferred stock, shares authorized (in shares) | 100.0M shares | 100.0M shares | ||
| Preferred stock, shares issued (in shares) | 0 shares | 0 shares | ||
| Preferred stock, shares outstanding (in shares) | 0 shares | 0 shares | ||
| Common stock, par value (in dollars per share) | $0.00 | $0.00 | ||
| Common stock, shares authorized (in shares) | 100.0M shares | 100.0M shares | ||
| Common stock, shares issued (in shares) | 35.5M shares | 33.5M shares | ||
| Common stock, shares outstanding (in shares) | 34.3M shares | 33.5M shares | ||
| Treasury stock, shares (in shares) | 1.1M shares | 6 shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $17.2M | $46.5M | ||
| Accounts receivable, net of provision for credit losses of $0.6 million and $0.3 million, respectively | $346.1M | $245.3M | ||
| Inventories | $253.7M | $247.1M | ||
| Contract assets | $112.5M | $103.8M | ||
| Prepaid expenses and other current assets | $40.6M | $28.4M | ||
| Total current assets | $770.1M | $671.1M | ||
| Property, plant and equipment, net | $536.4M | $465.8M | ||
| Goodwill | $1.1B | $1.0B | $994.0M | |
| Other intangible assets, net | $825.4M | $778.3M | ||
| Deferred income taxes | $9.0M | $8.3M | ||
| Operating lease assets | $98.4M | $86.1M | ||
| Financing lease assets | $37.1M | $27.7M | ||
| Other long-term assets | $23.2M | $23.0M | ||
| Total assets | $3.4B | $3.1B | ||
| Current portion of long-term debt | $0 | $10.0M | ||
| Accounts payable | $113.1M | $101.5M | ||
| Operating lease liabilities | $9.1M | $7.4M | ||
| Accrued expenses and other current liabilities | $109.8M | $108.3M | ||
| Total current liabilities | $232.0M | $227.2M | ||
| Long-term debt | $1.2B | $980.2M | ||
| Deferred income taxes | $116.3M | $124.6M | ||
| Operating lease liabilities | $81.9M | $77.7M | ||
| Financing lease liabilities | $28.6M | $23.8M | ||
| Other long-term liabilities | $19.9M | $25.4M | ||
| Total liabilities | $1.7B | $1.5B | ||
| Preferred stock, $0.001 par value, authorized 100,000,000 shares; no shares issued or outstanding | $0 | $0 | ||
| Common stock, $0.001 par value; 100,000,000 shares authorized; 35,481,805 and 33,546,262 shares issued, respectively, and 34,346,450 and 33,546,256 outstanding, respectively | $35.0K | $34.0K | ||
| Additional paid-in capital | $771.2M | $742.0M | ||
| Treasury stock, at cost, 1,135,355 shares and 6 shares, respectively | -$76.9M | $0 | ||
| Retained earnings | $994.1M | $891.2M | ||
| Accumulated other comprehensive income (loss) | $58.2M | -$14.0M | ||
| Total stockholders equity | $1.7B | $1.6B | $1.5B | $1.4B |
| Total liabilities and stockholders equity | $3.4B | $3.1B | ||
| Allowance for doubtful accounts | $600.0K | $300.0K | ||
| Preferred stock, par value (in dollars per share) | $0.00 | $0.00 | ||
| Preferred stock, shares authorized (in shares) | 100.0M shares | 100.0M shares | ||
| Preferred stock, shares issued (in shares) | 0 shares | 0 shares | ||
| Preferred stock, shares outstanding (in shares) | 0 shares | 0 shares | ||
| Common stock, par value (in dollars per share) | $0.00 | $0.00 | ||
| Common stock, shares authorized (in shares) | 100.0M shares | 100.0M shares | ||
| Common stock, shares issued (in shares) | 35.5M shares | 33.5M shares | ||
| Common stock, shares outstanding (in shares) | 34.3M shares | 33.5M shares | ||
| Treasury stock, shares (in shares) | 1.1M shares | 6 shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.6
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income | $102.8M | $119.9M | $90.7M |
| Depreciation and amortization | $130.7M | $111.0M | $98.8M |
| Debt related charges included in interest expense | $6.9M | $4.1M | $8.1M |
| Debt conversion inducement expense | $46.7M | $0 | $0 |
| Inventory step-up amortization | $0 | $1.1M | $590.0K |
| Stock-based compensation | $23.2M | $24.8M | $23.3M |
| Non-cash lease expense | $10.2M | $9.1M | $11.2M |
| Non-cash (gain) loss on equity investments | -$550.0K | $780.0K | $5.7M |
| Contingent consideration fair value adjustment | -$2.3M | -$3.5M | -$736.0K |
| Other non-cash losses | $1.7M | $7.0M | $4.4M |
| Deferred income taxes | -$2.7M | -$14.1M | -$9.5M |
| Gain on sale of discontinued operations | -$46.0K | -$177.0K | $0 |
| Accounts receivable | -$82.4M | -$6.5M | -$7.4M |
| Inventories | -$2.6M | -$18.1M | -$30.2M |
| Contract assets | -$7.3M | -$18.4M | -$13.6M |
| Prepaid expenses and other assets | -$2.5M | -$229.0K | -$930.0K |
| Accounts payable | -$566.0K | -$16.6M | -$520.0K |
| Accrued expenses and other liabilities | -$20.3M | $4.5M | $7.9M |
| Income taxes payable | -$4.9M | $811.0K | -$7.5M |
| Net cash provided by operating activities | $196.1M | $205.2M | $180.2M |
| Acquisition of property, plant and equipment | -$91.0M | -$105.4M | -$119.9M |
| Acquisitions, net of cash acquired | -$178.9M | -$138.5M | -$43.6M |
| Proceeds (settlement of working capital) from sale of discontinued operations, net | -$950.0K | $48.7M | $0 |
| Other investing activities | $123.0K | -$211.0K | $173.0K |
| Net cash used in investing activities | -$270.7M | -$195.4M | -$163.4M |
| Principal payments of long-term debt | -$667.7M | -$6.0K | -$415.9M |
| Proceeds from issuance of convertible notes, net of discount | $977.5M | $0 | $486.2M |
| Proceeds from revolving credit facility | $307.0M | $274.5M | $383.1M |
| Payments of revolving credit facility | -$433.0M | -$247.5M | -$424.8M |
| Purchase of capped calls | -$71.0M | $0 | -$35.0M |
| Payment of debt issuance costs | -$1.4M | -$2.1M | -$2.2M |
| Repurchases of common stock | -$50.0M | $0 | $0 |
| Proceeds from the exercise of stock options | $3.6M | $742.0K | $2.3M |
| Tax withholdings related to net share settlements of restricted stock units | -$16.9M | -$10.9M | -$3.1M |
| Payment of contingent consideration | $0 | $0 | -$7.7M |
| Principal payments on finance leases | -$5.9M | -$10.7M | -$1.2M |
| Other financing activities | $1.4M | $9.3M | $190.0K |
| Net cash provided by (used in) financing activities | $43.6M | $13.3M | -$18.0M |
| Effect of foreign currency exchange rates on cash and cash equivalents | $1.6M | -$243.0K | $570.0K |
| Net increase (decrease) in cash and cash equivalents | -$29.4M | $22.9M | -$598.0K |
No quarter-by-quarter statement was filed.
Founded by Wilson Greatbatch in 1970.1
Who has led Integer, and when. Pick a name to see everywhere that person has worked.
378 filings to the SEC since October 2021: 5 annual reports, 16 quarterly reports, 60 major events, 227 insider forms, 19 large holders, 51 other. The latest 20:
The 378 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
31 open-market trades by officers, directors and large owners since October 2021: 6 buys and 25 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Thor Kirk KChief Human Resources Officer | Sale | 11,767 | $126.23 | $1.5M | Form 4 |
| Sep 14, 2026 | Thor Kirk KChief Human Resources Officer | Sale | 19,773 | $126.25 | $2.5M | Form 4 |
| Sep 8, 2026 | Senn AndrewPresident, Growth & Innovation | Sale | 9,408 | $126.30 | $1.2M | Form 4 |
| Mar 13, 2026 | Thomas Tommy PVP, Corporate Controller | Sale | 825 | $85.00 | $70.1K | Form 4 |
| Nov 12, 2025 | Harris John APresident, Glob Ops & Manu Tec | Buy | 1,650 | $70.00 | $115.5K | Form 4 |
| Nov 11, 2025 | Thomas Tommy PVP, Corporate Controller | Sale | 884 | $70.15 | $62.0K | Form 4 |
| Nov 7, 2025 | Smith DironEVP, Chief Financial Officer | Buy | 1,116 | $67.19 | $75.0K | Form 4 |
| Nov 6, 2025 | Capps Cheryl CDirector | Buy | 1,600 | $66.70 | $106.7K | Form 4 |
| Oct 30, 2025 | Khales PaymanPresident & CEO | Buy | 3,127 | $64.94 | $203.1K | Form 4 |
| Jun 5, 2025 | MAXWELL MARTIN CDirector | Sale | 8,720 | $120.56 | $1.1M | Form 4 |
| Jun 4, 2025 | Spence Donald JDirector | Sale | 14,739 | $120.38 | $1.8M | Form 4 |
| May 1, 2025 | Dziedzic Joseph WPresident & CEO | Sale | 338,975 | $123.17 | $41.8M | Form 4 |
| Jul 31, 2024 | Hobby Jean M.Director | Sale | 11,960 | $119.66 | $1.4M | Form 4 |
| Jul 31, 2024 | MAXWELL MARTIN CDirector | Sale | 4,700 | $118.88 | $558.7K | Form 4 |
| Jul 30, 2024 | Harris John APresident, Glob Ops & Manu Tec | Sale | 3,400 | $123.80 | $420.9K | Form 4 |
| Jun 4, 2024 | Harris John APresident, Glob Ops & Manu Tec | Sale | 1,521 | $120.44 | $183.2K | Form 4 |
| May 24, 2024 | Hinrichs James F.Director | Sale | 9,603 | $122.44 | $1.2M | Form 4 |
| May 10, 2024 | Khales PaymanPresident & CEO | Sale | 8,712 | $113.84 | $991.8K | Form 4 |
| May 7, 2024 | Harris John APresident, Glob Ops & Manu Tec | Sale | 312 | $113.00 | $35.3K | Form 4 |
| May 7, 2024 | Senn AndrewPresident, Growth & Innovation | Sale | 5,000 | $113.14 | $565.7K | Form 4 |
All 31 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| BlackRock, Inc. | 5,353,741 | $500.3M | 0.0% | +47,900 |
| Invesco Ltd. | 2,247,031 | $210.0M | 0.0% | +277,898 |
| Vanguard Portfolio Management LLC | 2,040,469 | $190.7M | 0.0% | −6,497 |
| Dimensional Fund Advisors LP | 1,627,784 | $152.1M | 0.0% | +143,388 |
| Nomura Holdings Inc | 1,554,450 | $145.3M | 0.6% | +1,106,089 |
| Vanguard Capital Management LLC | 1,531,843 | $143.2M | 0.0% | −5,444 |
| State Street Corp | 1,413,174 | $132.0M | 0.0% | +14,888 |
| Morgan Stanley | 1,345,748 | $125.8M | 0.0% | −193,535 |
| Irenic Capital Management LP | 1,264,259 | $118.1M | 8.5% | +596 |
| Earnest Partners LLC | 1,008,519 | $94.2M | 0.3% | −32,629 |
| Hudson Bay Capital Management LP | 1,000,000 | $93.5M | 0.5% | No change |
| Citadel Advisors LLC | 965,753 | $90.2M | 0.1% | +272,696 |
| Geode Capital Management, LLC | 879,457 | $82.2M | 0.0% | +45,095 |
| Alliancebernstein L.P. | 913,117 | $80.4M | 0.0% | −390,267 |
| Massachusetts Financial Services Co /ma/ | 788,214 | $73.7M | 0.0% | −17,660 |
| Healthcare Of Ontario Pension Plan Trust Fund | 778,700 | $72.8M | 0.1% | −40,346 |
| Goldman Sachs Group Inc | 576,830 | $53.9M | 0.0% | +231,231 |
| Manufacturers Life Insurance Company, The | 544,942 | $50.9M | 0.0% | −53,584 |
| Brown Advisory Inc | 544,327 | $50.9M | 0.1% | New |
| Bank Of America Corp /de/ | 473,933 | $44.3M | 0.0% | −96,720 |
| Charles Schwab Investment Management Inc | 473,419 | $44.2M | 0.0% | +9,782 |
| Northern Trust Corp | 423,204 | $39.5M | 0.0% | +5,015 |
| CIBC Bancorp USA Inc. | 381,931 | $35.7M | 0.0% | −369,833 |
| William Blair Investment Management, LLC | 378,706 | $35.4M | 0.1% | +86,105 |
| Silvercrest Asset Management Group LLC | 371,484 | $34.7M | 0.2% | −29,285 |
13F reports cover disclosed long positions in U.S. stocks only.
The numbers on this page point here. Each one links to the record it came from.